The vaccine advisory committee of the Centers for Disease Control and Prevention is scheduled to meet Dec. 4 and 5. On the agenda: the hepatitis B vaccine, the overall childhood vaccine schedule and specific vaccine ingredients. We’ll summarize what we’ve written about these topics and what the committee has said about them in recent meetings.
Issues: residual DNA
CDC Vaccine Panel Presentation Distorts Research on Safety of mRNA COVID-19 Vaccines
A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel highlighted various alleged “safety uncertainties” of the mRNA COVID-19 vaccines, including those about cancer and changes to the immune system. Scientists, however, told us that many of the cited studies are either misconstrued or of poor quality.
Faulty Science Underpins Florida Surgeon General’s Call to Halt mRNA COVID-19 Vaccination
Posts Spread False Claim About Moderna Patent Application
The mRNA COVID-19 vaccines — like many other vaccines — can contain small amounts of DNA left over from the manufacturing process. There’s no evidence this residual DNA causes “turbo cancer,” or very aggressive cancer. Nor did Moderna admit that “mRNA Jabs Cause Turbo-Cancer,” contrary to an online article that misconstrues a line from a patent application.




